Smiths Group, the global technology company, today announces contracts won by Smiths Medical with a total value of over US$45 million.
The contracts have been won in the last two months by Smiths Medical’s Critical Care business, which provides safety needles and catheters, temperature management, airway and anaesthesia products to the US and international markets.
The contracts include:
- A renewal of a contract with a major Group Purchasing Organisation (GPO) for IV catheters for the US hospital market, worth $30m
- A further contract with the same GPO for hypodermic needles worth $5m
- Additional new and secured contracts with GPO customers covering Arterial Blood Gas sampling kits, circuits and masks (anaesthesia) and hyperinflation (resuscitation) worth almost $11m
The contracts have a duration of either two or three years.
Srini Seshadri, Group Managing Director for Smiths Medical, said: “We have had an excellent start to the year in our Critical Care business, and continue to win new agreements while securing relationships with the largest customers in the market, which is a testament to the quality of our product ranges, and the people who sell them.”